Globus Medical, Inc.

Total Valuation

Globus Medical, Inc. carries a market capitalization of 10.48B, placing it among publicly traded companies globally. Its enterprise value stands at 11.11B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

Globus Medical, Inc. currently has 135.67M shares outstanding.

Valuation Ratios

Globus Medical, Inc. trades at a trailing price-to-earnings ratio of 19.81. The price-to-sales ratio is 3.75, and the price-to-book ratio stands at 7.68.

Enterprise Valuation

On an enterprise value basis, Globus Medical, Inc. trades at an EV/EBITDA multiple of 12.59 and an EV/FCF ratio of 11.67. The EV/Sales ratio of 3.58 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 18.48 provides insight into valuation relative to core operating earnings.

Financial Position

Globus Medical, Inc. maintains a current ratio of 4.56, meaning it holds 4.6x the short-term assets needed to cover near-term liabilities.

Financial Efficiency

Globus Medical, Inc. posts a return on equity of 46.04 and a return on invested capital of 11.82.

Taxes

Over the trailing twelve months, Globus Medical, Inc. has paid 71.77M in income taxes, reflecting an effective tax rate of 10.90.

Stock Price Statistics

Globus Medical, Inc.'s stock has gained approximately 32.04213% over the past 52 weeks. The 50-day moving average sits at 85.95, while the 200-day moving average is 80.58.

Income Statement

Over the trailing twelve months, Globus Medical, Inc. generated 3.10B in revenue and converted that into 586.71M in net income, yielding earnings per share of 4.29. EBITDA reached 882.15M, while operating income came in at 601.11M.

Balance Sheet

Globus Medical, Inc. holds 629.85M in cash and equivalents against 115.22M in total debt, resulting in a net debt position of -560.95M. Total book value stands at 1.51B, with working capital of 1.72B providing operational flexibility.

Cash Flow

Globus Medical, Inc. produced 778.51M in operating cash flow over the past twelve months. After subtracting -172.94M in capital expenditures, free cash flow totaled 605.57M - equivalent to 4.49 per share.

Margins

Globus Medical, Inc. operates with a gross margin of 67.86, reflecting its pricing power and cost economics. The operating margin of 19.39 and net profit margin of 18.92 provide insight into operational efficiency.

Dividends & Yields

Scores

Globus Medical, Inc. posts an Altman Z-Score of 12.68, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.